Daptomycin
Daptomycin is a prescription antibiotic used intravenously to treat serious bacterial infections, such as those caused by Gram-positive bacteria. It belongs to the lipopeptide class and is available as a 500 mg powder for injection, manufactured by Dr. Reddy's Laboratories. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Daptomycin is a prescription antibiotic used intravenously to treat serious bacterial infections, such as those caused by Gram-positive bacteria. It belongs to the lipopeptide class and is available as a 500 mg powder for injection, manufactured by Dr. Reddy's Laboratories. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Daptomycin", "mediaType": "text/html", "description": " Access the FDA dataset for Daptomycin — ANDA 211403 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211403" } ] |
| identifier | ANDA211403 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "drug-manufacturers", "drug-safety", "health-care", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Daptomycin |
